These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3602018)

  • 1. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency.
    Brooks PM; McCredie M; Prowse M; Podgorski M; Forrest M; Munro I; Boutagy J; Pei-Ling L
    Pharmatherapeutica; 1986; 4(10):665-72. PubMed ID: 3602018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects.
    Hobbs DC
    Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis.
    Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J
    Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of piroxicam: new aspects.
    Fenner H
    Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of impairment of renal function on the accumulation and disposition of isoxicam.
    Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF
    Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antirheumatic treatment in old age and its effect on kidney function].
    Jansen W
    Med Klin; 1981 Aug; 76(17):476-8. PubMed ID: 7278786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly.
    Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of isoxicam pharmacokinetics in young and elderly subjects.
    George CF; Renwick AG; Darragh AS; Hosie J; Blake D; van Marle W; Frank GJ
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):129S-134S. PubMed ID: 3620272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compared effects of isoxicam and indomethacin on the urinary excretion of prostaglandins in degenerative articular diseases.
    Sassard J; Geoffroy J; Ferry N; Benzoni D; Mathieu M; Lejeune E; Llorca G
    Prostaglandins Leukot Essent Fatty Acids; 1989 Nov; 38(2):107-11. PubMed ID: 2616586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of isoxicam in hepatic disease.
    Ferry N; Cuisinaud G; Ouzan D; Trepo C; Sassard J
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):143S-147S. PubMed ID: 2887185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome caused by isoxicam].
    Capizzi R; Cacciaguerra MG; Guerriero G; Tulli A
    G Ital Dermatol Venereol; 1986; 121(6):461-2. PubMed ID: 3557542
    [No Abstract]   [Full Text] [Related]  

  • 15. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
    Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
    Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function.
    Beermann B; Odlind B; Wibell L
    Clin Nephrol; 1983 Mar; 19(3):124-31. PubMed ID: 6839561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of etodolac in subjects with renal impairment.
    Brater DC
    Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis.
    Grace EM; Rosenfeld JM; Sweeney GD; Buchanan WW
    Curr Med Res Opin; 1987; 10(9):580-91. PubMed ID: 3436154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy and tolerance of a new non-steroidal anti-inflammatory agent, isoxicam].
    Marcolongo R; Giordano N; Fioravanti A; Frati E; Mariani AM; Casini A
    Clin Ter; 1984 Dec; 111(6):513-9. PubMed ID: 6525811
    [No Abstract]   [Full Text] [Related]  

  • 20. Lowering of plasma isoxicam concentrations with acetylsalicylic acid.
    Grace EM; Mewa AA; Sweeney GD; Rosenfeld JM; Darke AC; Buchanan WW
    J Rheumatol; 1986 Dec; 13(6):1119-21. PubMed ID: 3560102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.